KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $566.9 million.

  • Idexx Laboratories' Receivables - Net rose 1088.14% to $566.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $566.9 million, marking a year-over-year increase of 1088.14%. This contributed to the annual value of $473.6 million for FY2024, which is 352.61% up from last year.
  • As of Q3 2025, Idexx Laboratories' Receivables - Net stood at $566.9 million, which was up 1088.14% from $560.6 million recorded in Q2 2025.
  • Idexx Laboratories' Receivables - Net's 5-year high stood at $566.9 million during Q3 2025, with a 5-year trough of $368.3 million in Q4 2021.
  • Moreover, its 5-year median value for Receivables - Net was $452.7 million (2023), whereas its average is $453.2 million.
  • In the last 5 years, Idexx Laboratories' Receivables - Net surged by 2727.12% in 2021 and then skyrocketed by 300.24% in 2022.
  • Over the past 5 years, Idexx Laboratories' Receivables - Net (Quarter) stood at $368.3 million in 2021, then rose by 8.76% to $400.6 million in 2022, then grew by 14.18% to $457.4 million in 2023, then rose by 3.53% to $473.6 million in 2024, then rose by 19.7% to $566.9 million in 2025.
  • Its last three reported values are $566.9 million in Q3 2025, $560.6 million for Q2 2025, and $527.5 million during Q1 2025.